Recall Register

Food, drugs, devices › LeMaitre Vascular, Inc.

Device recall: LeMaitre Vascular Tumescent Catheter Inversion (TCI) System. The TCI System is intended to provide a system to the remov

FDA enforcement event 70698 · Class III · initiated 24 Feb 2015 · status Terminated · terminated 21 May 2015

DeviceVoluntary: Firm initiated1 product recordBurlington, MA

FDA enforcement event 70698 is a device recall by LeMaitre Vascular, Inc. of Burlington, MA, initiated 24 Feb 2015 and classified Class III, with 1 product record.

FDA defines Class III as a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences. 4% of the 1,153 device enforcement events initiated in 2015 carry the same class.

Status: Terminated, terminated 21 May 2015. Initiation: voluntary: firm initiated. LeMaitre Vascular, Inc. has 20 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

LeMaitre Vascular, Inc., Burlington, MA.

Reason for recall

"Mislabeled with an incorrect expiration date"

Distribution

"CA, CO, KS, MN, UT, WA, WI"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1294-2015LeMaitre Vascular Tumescent Catheter Inversion (TCI) System. The TCI System is intended to provide a system to the removal of an incompetent greater saphenous vein. Catalog Number: 7210023, lot #6104925254 unitsClass IIITerminated25 Mar 2015

Context

4%of 2015 device events are Class III1,153 events that year
1product record in this eventfirm median: 1
20events on this register for the firm

Other enforcement events for LeMaitre Vascular, Inc.

InitiatedProduct (first record)TypeClassRecords
10 Feb 2026Artegraft Vascular Graft; REF#: AG740;DeviceClass II1
25 Sep 2025Artegraft¿ Collagen Vascular Graft; REF: AG1015;DeviceClass II1
2 Sep 2025Artegraft Collagen Vascular Grafts Model Numbers: (1) AG 616, (2) AG 630, (3) AG 636, (4) AG 640, (5) AG 645, (6) AG 715DeviceClass II1
25 Aug 2025Artegraft Collagen Vascular Graft. Model/Catalog/Part Numbers: AG630M, AG636M, AG730M, AG740M, AG845M. The Artegraft is DeviceClass II1
11 Apr 2025TufTex Over-the-Wire Embolectomy Catheter. All Catalog numbers: 1651-34, 1651-38, 1651-44, 1651-48, 1651-58, 1651-64, 16DeviceClass II3
17 Apr 2024Syntel Silicone Thrombectomy Catheter, Sterile, Rx Only. Used in vascular grafts and peripheral venous thrombectomies.DeviceClass II1
13 Jul 2023The Chevalier Valvulotome is a device used to disrupt the valves of veins which are to be used as grafts in the in situ DeviceClass II1
30 Sep 2022TufTex Embolectomy Catheter, Model No. This catheter has a latex balloon and a single lumen extrusion. It is inserted usDeviceClass II1
6 Apr 2021LeverEdge Contrast Injector: 35 cc syringe with ISO 594 female luer lock - Product Usage: intended to be used to perfuseDeviceClass II1
23 Mar 2020LeMaitre 5F Plus Over the Wire Embolectomy Catheter, Model Nos. 1651-84, e1651-84, 1651-88, e1651-88. The LeMaitre Over DeviceClass I1

All 20 events for LeMaitre Vascular, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Mislabeled with an incorrect expiration date"

What does Class III mean?

FDA classifies recalls by relative degree of health hazard. Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.

Where was the product distributed?

FDA's distribution pattern field reads: "CA, CO, KS, MN, UT, WA, WI"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 21 May 2015. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.